VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
GLPG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
GLPGGalapagos N.V.
$27.93$1.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
GLPG logo

Galapagos N.V.

GLPG
NASDAQ · Biotechnology
$27.93
At close - Aug 26, 4:00 PM EDT - USD
Market Cap$1.84B
P/E4.9x
52W High$37.78
Volume375.2K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

Revenue Volatility Masks Structural Clinical Burn Risk

Galapagos N.V. faces a precarious transition as it pivots toward early-stage oncology, with its financial health heavily dependent on non-recurring milestone payments rather than sustainable commercial product demand. The company's reliance on high-burn R&D, w...

GrowthContracting
ProfitabilityNegative
ValuationAttractive
TechnicalsWeak
Explore valuation models
MARKET ACTION

GLPG price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

8/12 Beats

EPS beat 8 of last 12 quarters

02

Valuation risk

-83% Peers

P/E is 83% below peer median

03

Market leadership

RS 33 · Lag

Laggard (Underperforming 67% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Aug 6

Market performance

Price History →

Trailing total returns as of 10/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
GLPG-15.29%
S&P 500 (^GSPC)+11.83%
1-Year Return
GLPG-20.29%
S&P 500 (^GSPC)+14.29%
3-Year Return
GLPG-18.81%
S&P 500 (^GSPC)+78.79%
5-Year Return
GLPG-47.88%
S&P 500 (^GSPC)+73.40%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
4.9x
Forward P/E
N/A
EV/EBITDA0th %ile
2.7x
FCF YieldCash Flow
N/A

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
4.9x
12.7x
0th· Low
EV/EBITDA
2.7x
3.7x
0th· Low
Price/FCF
N/A
N/A
N/A
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$141.50+406.6%
Base (Fair)$200.51+617.9%
Bull$326.15+1067.7%
$141.50 Bear$200.51 Base$326.15 Bull
Current Market Price: $27.93
Trades at a 86.1% discount to Base DCF ($200.51)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue
$1.11B+303.5% YoY
Net income
$321M+333.1% YoY
Free cash flow
-$202M+49.7% YoY
Operating margin
45.1%+113.4 pts YoY
ROIC (TTM)12.5%
Avg ROIC 5Y-
ROE (TTM)10.5%
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate8/12 (67%)
Revenue Beat Rate6/12 (55%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026Latest
May 6, 2026
$0.25+119.7%
vs -$1.27
$9M-20.4%
vs $11M
Q1 2026
Feb 23, 2026
$16.38+1538.0%
vs $1.00
$1.2B+1370.9%
vs $84M
Q4 2025
Nov 5, 2025
-$3.59-1696.4%
vs -$0.20
$83M+4.0%
vs $80M
Q3 2025
Jul 23, 2025
-$1.89-182.3%
vs -$0.67
$77M-5.1%
vs $81M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
04

Compare before deciding

Benchmark GLPG against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Galapagos N.V. (GLPG)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
GLPG logoGLPGGalapagos N.V.Current
$27.93$1.84B4.93303.5%28.85%10.47%—
ARCT logoARCTArcturus Therapeutics Holdings Inc.
$13.21$375.47M-5.50-51.43%-391.9%-46.54%—
ACAD logoACADACADIA Pharmaceuticals Inc.
$19.89$3.41B8.6911.87%33.42%32.39%—
HALO logoHALOHalozyme Therapeutics, Inc.
$106.94$12.68B41.7737.55%24.86%180.63%—
EXEL logoEXELExelixis, Inc.
$57.94$14.56B20.846.98%35.33%42.49%—
IONS logoIONSIonis Pharmaceuticals, Inc.
$44.00$7.31B-18.4933.87%-64.64%-110.84%—

Compare GLPG vs Peers

Galapagos N.V. (GLPG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ARCT

Most directly comparable listed peer for GLPG.

Scale Benchmark

vs LLY

Larger-name benchmark to compare GLPG against a more recognizable public peer.

Peer Set

Compare Top 5

vs ARCT, ACAD, HALO, EXEL

Get notified when GLPG posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

GLPG Frequently Asked Questions

Galapagos N.V. (GLPG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Galapagos N.V.'s revenue?

Galapagos N.V. (GLPG) reported $1.04B in revenue for fiscal year 2025. This represents a 13321% increase from $7.8M in 2004.

How fast is Galapagos N.V. growing?

Galapagos N.V. (GLPG) grew revenue by 303.5% over the past year. This is strong growth.

Is GLPG profitable?

Yes, Galapagos N.V. (GLPG) is profitable, generating $488.8M in net income for fiscal year 2025 (28.8% net margin).

Dividend & Returns
What is GLPG's return on equity?

Galapagos N.V. (GLPG) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.

What is Galapagos N.V.'s free cash flow?

Galapagos N.V. (GLPG) had negative free cash flow of $304.5M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in GLPG back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →